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The catcemic response to PTH in the rat: Effect of elevated PTH levels
and uremia. Secondary hyperparathyroidism (2° HPT) is a consistent
finding in renal failure. A decreased calcemic response (CR) to parathy-
roid hormone (PTH) contributes to the development of 2° HPT. Since
parathyroidectomy (PTX) corrects the decreased CR to PTH in azotemic
animals, down-regulation of PTH receptors induced by an elevation of
PTH has been advanced as an important factor in the development of 2°
HPT. The goal of the study was to determine in azotemic rats whether a
progressive reduction of PTH improves the CR to PTH and whether the
maintenance of normal PTH levels corrects the CR to PTH. Seven groups
of pair-fed rats were studied. Three groups of rats had normal renal
function (NRF groups) and received either a high phosphorus (HPD-
NRF), a moderate phosphorus (MPD-NRF), or a low phosphorus (LPD-
NRF) diet. Three azotemic (NX) groups received similar diets (HPD-NX,
MPD-NX and LPD-NX groups) in order to vary the magnitude of 2° HPT.
A PTX was performed in a fourth azotemic group (PTX-NX) to induce
the complete absence of PTH. After 14 to 16 days on the maintenance
diets, the CR to PTII was determined with a 48 hour infusion of 1-34 rat
PTH. Serum PTH levels in the NRF groups were 48 4 (HPD-NRF),
40 2 (MPD-NRF) and 35 2 (LPD-NRF) pg/mI and in the NX groups
were 327 24 (HPD-NX), 86 6 (MPD-NX) and 49 3 (LPD-NX)
pg/mi; serum PTH levels were greater in the NX groups than the
respective NRF dietary control (P < 0.01). The CR to PTH was similar in
the three NRF groups and the PTX-NX group, and less in each of the
three NX groups than the respective dietary control in the NRF groups
(P < 0.001). The CR to PTH was similar in the HPD-NX and MPD-NX
groups despite an almost fourfold difference in PTH. The P1'H level in the
LPD-NX group was similar to the PTH level of the HPD-NRF group
(49 3vs. 48 4 pg/mi). Nevertheless, despite similar PTH, phosphorus,
and calcitriol levels, the CR to PTH was less in the LPD-NX than the
HPD-NRF group (4.1 0.5 vs. 8.3 0.3 mg/di, P < 0.001). Urinary
calcium and phosphorus excretion were similar in all groups and thus
could not account for the differences in the CR to PTH. In a second study,
the CR to PTH was greater in non-azotemic PTX rats than both azotemic
PTX rats and normal rats (P < 0.01). In summary, (1) PTX corrected the
CR to PTH in renal failure to the range observed in normal rats; (2) a
significant reduction of PTH levels by dietary manipulation did not
improve the CR to PTH; (3) maintenance of normal PTH levels did not
correct the CR to PTH; and (4) PTX also improved the CR to PTH in rats
with normal renal function. In conclusion, our results suggest that the
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mechanism by which PTX restores the CR in uremia may include factors
other than down-regulation of PTH receptors, and uremia may be an
independent factor contributing to the decreased CR to PTH.
Secondary hyperparathyroidism (2° HPT) is a consistent finding
in azotemic animals and patients [1—6]. Skeletal resistance to the
calcemic action of parathyroid hormone (PTH) is considered to
be an important pathogenic factor in the development of 2° HPT
[1—3, 7—10]. This decreased calcemic response (CR) to PTH
induces 2° HPT because higher PTH levels are required to
maintain normal serum calcium levels. Several factors which
contribute to the skeletal resistance to the calcemic action of PTH
in renal failure have been identified. These include phosphorus
retention [1, 11, 12], a deficiency of calcitriol [2, 13—151, and most
recently, down-regulation of bone receptors for PTH [2, 16].
Since phosphorus retention has consistently been shown to
decrease the CR to PTH [1, 3, 11], there is uniform agreement
that phosphorus retention is an important pathogenic factor in the
induction of skeletal resistance to the calcemic action of PTH,
However, whether a calcitriol deficiency contributes to the im-
paired CR to PTH has been more debated. Massry et al observed
that calcitriol administration improved the CR to PTH in dogs
with renal failure [13, 14]; similar results have been reported by
others [2, 17]. However, other investigators have not been able to
confirm these findings [15, 16].
While both phosphorus restriction and calcitriol supplementa-
tion have been shown to improve the CR to PTH, neither one
alone nor both together corrects the CR to PTH [1, 2, 13, 15, 17].
Conversely, Galceran et al reported that the removal of circulat-
ing PTH by thyroparathyroidectomy restored the CR to PTH to
normal in the azotemic dog [161. Studies in the azotemic rat have
also shown that selective parathyroidectomy (PTX) normalized
the CR to PTH [2]. As a result of these studies, the concept has
been advanced that elevated PTH levels induce down-regulation
of bone receptors for PTH and the elimination of PTH by PTX
restores the responsiveness of these receptors [2,16]. Neverthe-
less, the relation between PTX and down-regulation of PTH
receptors has not been directly established and the possibility that
PTX could restore the CR to PTH by a different mechanism has
not been excluded.
Since it has been advocated that elevated P1'H levels in renal
failure induce downregu1ation of PTH receptors resulting in a
decreased CR to PTH, the goals of our study were: (1) to evaluate
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Table 1. Groups included in the study
Normal renal function (NRF) groups
High phosphorus diet (HPD) (HPD-NRF group)
Moderate phosphorus diet (MPD) (MPD-NRF group)
Low phosphorus diet (LPD) (LPD-NRF group)
Azotemic (NX) groups
High phosphorus diet (HPD) (HPD-NX group)
Moderate phosphorus diet (MPD) (MPD-NX group)
Low phosphorus diet (LPD) (LPD-NX group)
Parathyroidectomy (PTX) (PTX-NX group)
whether a progressive reduction of PTH levels in renal failure
improves the CR to PTH, and (2) to establish whether the
maintenance of normal PTH levels in azotemic rats corrects the
CR to PTH.
Methods
Male Wistar rats weighing 120 to 160 grams were selected for
study. All rats underwent arterial ligation of 2 of the 3 hilar
branches of the left main renal artery or sham operation. This was
followed one week later by a right nephrectomy or sham opera-
tion. During surgical procedures, rats were anesthetized with 50
mg/kg of sodium pentobarbital (Nembutal, Abbott Laboratories,
Chicago, Illinois, USA) administered intraperitoneally. Rats were
housed in individual cages and pair-fed; each rat received 14
grams of food daily and was allowed free access to water. Rats not
ingesting at least 12 grams of food daily were removed from the
study.
Three diets containing different amounts of phosphorus were
used to vary the magnitude of 20 HPT: (1) a high phosphorus diet
(HPD; 1.2% phosphorus) to induce severe 2° HPT [1, 3, 18]; (2)
a moderate phosphorus diet (MPD; 0.6% phosphorus) to mini-
mize the magnitude of 2° HPT [3, 19]; and (3) a low phosphorus
diet (LPD; 0.2% phosphorus) to prevent the development of 2°
HPT [5, 6, 20]. All diets were provided by the same supplier (ICN
Biomedicals, Cleveland, Ohio, USA) and contained 0.6% calcium
and 100 IU of vitamin D per 100 g of diet. After 14 to 16 days on
the respective diets, blood was obtained after overnight fasting for
determination of serum calcium, phosphorus, creatinine, PTH
and calcitriol.
Six groups were defined according to the serum creatinine and
maintenance diets (Table 1). Sham operated rats had normal
renal function (NRF) and received either a high phosphorus
(HPD-NRF), moderate phosphorus diet (MPD-NRF), or low
phosphorus (LPD-NRF) diet. Azotemic (NX) rats received either
a high phosphorus (HPD-NX), moderate phosphorus (MPD-
NX), or low phosphorus (LPD-NX) diet. An azotemic group of
parathyroidectomized rats (PTX-NX) was included in order to
compare the CR to PTH with the three NRF and three NX
groups. A selective PTX was performed as previously described at
the time of arterial ligation of the left kidney [2]. To validate the
effectiveness of the PTX, rats were maintained on a 0.6% calcium
and 0.6% phosphorus diet for three days at which time blood was
obtained; only rats with a serum calcium level less than 7 mg/dl
were included in the study. In order to prevent severe hypocalce-
mia, these rats received 14 to 16 g/day of a high calcium diet
(HCaD) containing 1.2% calcium and 0.6% phosphorus; this diet
had the same caloric and vitamin D content as the other diets.
In the LPD-NX group, the goal was to study azotemic rats with
PTH levels in the normal range. In an attempt to further insure
normal PTH levels, six of the rats in this group underwent a
unilateral PTX at the time of arterial ligation of the left kidney.
However, the prevention of elevated PTH levels was not improved
by this procedure. Of the 12 rats initially entered into the
LPD-NX group, only the six rats with PTH levels in the normal
range were included in the study; of these rats, three had
unilateral parathyroidectomy. These restrictive selection criteria
were used to exclude rats with elevated PTH levels and avoid the
possibility that mild PTH elevations could result in down-regula-
tion of PTH receptors.
To evaluate the CR to PTH, a 48 hour PTH infusion was
performed 14 to 16 days after the right nephrectomy or sham
operation. The use of this method to determine the CR to PTH
has been described in detail previously [1, 2]. Briefly, 1-34 rat PTH
(Bachem, Torrance, California, USA) from a single lot was
administered at a constant rate of 0.11 jtg/100 g body wt!hr via a
subcutaneously implanted miniosmotic pump (Model 2001, Alza,
Palo Alto, California, USA). The CR to PTH was defined as the
increase in serum calcium (postinfusion calcium minus basal
calcium) after the 48-hour PTH infusion. During the PTH infu-
sion rats received a diet with negligible amounts of calcium and
phosphorus (0% calcium, 0.16% phosphorus); this diet was used
to minimize the effect of gastrointestinal absorption of calcium
and phosphorus.
To determine whether the high calcium maintenance diet used
in the PTX-NX group affected the CR to PTH, the same high
calcium diet was also given for 14 to 16 days to parathyroid-intact
normal (HCaD-NRF) and azotemic rats (HCaD-NX). The 48
hour infusion of PTH was performed as already described to
determine the CR to PTH. Both groups of rats were also
maintained on the same 0% calcium, 0.16% phosphorus diet
during the PTH infusion.
Since PTX restored the CR to PTH to normal in azotemic rats,
an additional study was performed to determine whether PTX
further increased the CR to PTH in rats with normal renal
function. In previous studies we determined that it was difficult to
achieve a CR to PTH greater than the serum calcium of 18 mg/dl
generally observed in normal rats after the PTI-1 infusion. Thus, to
maximize the ability to detect differences between the PTX and
the non-PTX groups, it was decided to start from a lower serum
calcium and to decrease the dose of PTH infused. To accomplish
this goal, the amount of high calcium diet was decreased to 12
glday and the dose of PTH infused for 48 hours was reduced to
0.066 JLg/100 g body wt/hr of 1-34 rat PTH; this PTH dose is 60%
of the usual dose of PTH infused in our studies [1—3].
To evaluate whether differences in urinary calcium and phos-
phorus excretion could account for the observed differences in the
CR to PTH, a 24 hour urine for calcium and phosphorus was
collected in a subset of rats in each group during the last day of the
study diet and during the 48-hour PTH infusion. Rats were
housed in individual metabolic cages during the urinary collec-
tions.
Serum calcium was measured by atomic absorption (Perkin
Elmer, Norwalk, Connecticut, USA); serum creatinine with a
creatinine analyzer (Beckman Instruments, Fullerton, California,
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Table 2. Biochemical data in normal and azotemic rats
NormaI renal function (NRF) Azotemic(NX)
HPD-NRF MPD-NRF LPD-NRF HPD-NX MPD-NX LPD-NX PTX-NX
Creatinine mg/dl
Calcium mg/dl
Phosphorus mg/dl
PTH pg/mI
Calcitriol pg/mi
Calcemic response to PTH mg/dl
N
0.3 0.1
10.1 0.1
8.1 0.3
48 4
187 9
8.3 0.3
11
0.3 0.1
9.9 0.1
8.6 0.3
40 2
200 16
9.1 0.4
7
0.3 0.1
10.2 0.1
9.1 0.3
35 2C
241 7
9.1 0.4
6
0.9 0.1'
8.3 03ab
12 08ab
327 24ab
78 12'
2.9 0.2a
14
0.8 0.la
10.0 0.1
8.2 0.386 6
220 26
3.5 0.2a
9
0.8 0.1
10.4 0.2
8.7 0.4
49 3
247 20
4.1 0.5a
6
0.9 0.1
7.8 04b
12.1 0.7'
ND
NM
7.7 O.6f
11
moderate phosphorus diet; LPD, low phosphorus diet; ND, nonData are mean SE. Abbreviations are: HPD, high phosphorus diet; MPD,
detectable; NM, not measured.
aP < 0.05 vs. NRF group on the same diet
b P < 0.05 vs. MPD-NX and LPD-NX groups
cp < 0.05 vs. HPD-NRF group
d P < 0.05 vs. other MPD-NX group
P < 0.05 vs. MPD-NRF group
1'p < 0.05 vs. other NX groups
USA); and serum phosphorus, urinary calcium and urinary phos-
phorus with specific kits (Sigma Diagnostics, St. Louis, Missouri,
USA). Serum PTH was determined using an amino-terminal
radioimmunoassay (INS, Nichols Institute, San Juan Capistrano,
California, USA); this assay has been validated previously for the
determination of circulating PTH in the rat [1—3, 18, 21]. Serum
calcitriol was measured using a radioreceptor assay (Nichols
Institute; San Juan Capistrano, California, USA) as previously
reported [1—3]. Since the measurement of calcitriol requires a
large aliquot of serum, calcitriol was determined in a separate
group of rats which were sacrificed before the PTH infusion.
Statistics
Comparisons of the means among groups with the same renal
function (different diet) were assessed by ANOVA followed by
the Duncan's multiple comparison test. Comparisons between two
groups of rats on the same diet (different renal function) were
assessed by the unpaired Student's t-test. Paired comparisons
were assessed by the paired Student's t-test. Results are expressed
as the mean standard error (SE) and a P value < 0.05 was
considered significant.
Results
Shown in Table 2 are the biochemical data obtained 14 to 16
days after the right nephrectomy or sham operation and immedi-
ately before the PTH infusion. As designed, serum creatinine was
greater in the azotemic (NX) than the normal (NRF) groups (P <
0.001), and was not different among the NRF groups and among
the NX groups. Serum calcium and phosphorus levels were similar
in the NRF groups. Among the NX groups, serum calcium was
lower and serum phosphorus was greater in the HPD-NX and
PTX-NX groups than the other two NX groups (P < 0.002).
As shown in Table 2 and Figure 1, among the three NRF
groups, serum PTH was greater in the HPD-NRF than the
LPD-NRF group (P < 0.05). Serum PTH levels were greater in
the NX groups than their respective dietary-control NRF group
(P < 0.01). Among the NX groups, serum PTH was greater in the
HPD-NX group than the MPD-NX and LPD-NX groups (P <
0,001) and greater in the MPD-NX than the LPD-NX group (P <
0.001). The PTH level in the PTX-NX group was at the lowest
NRF groups NX groups
Fig. 1. Shown are the serum PTH levels in rats with normal renal function(NRF groups) and rats with renal failure (NX groups). The different
maintenance diets are shown under each bar: HPD, high phosphorus diet;
MPD, moderate phosphorus diet; LPD, low phosphorus diet. Parathyroid-
ectomy (PTX) was performed in an additional NX group. * P < 0.05 vs.
HPD; # P < 0.05 vs. NRF groups on similar maintenance diet.
level of sensitivity for the assay and thus was considered unde-
tectable.
Serum calcitriol levels were higher in the LPD-NRF group than
the other two NRF groups (P < 0.05, Table 2). Serum calcitriol
levels in the HPD-NX group were lower than in the HPD-NRF
group (P < 0.001) and lower than in the MPD-NX and LPD-NX
groups (P < 0.001). Serum calcitriol levels were similar in the
MPD-NX and LPD-NX groups, and similar in those two groups as
their respective NRF dietary controls.
The CR to PTH was similar in the three NRF groups and also
when the comparison included the PTX-NX group (Table 2 and
Fig. 2). Among the NX groups, the CR to PTH was greater in the
LPD-NX than the HPD-NX group (P < 0.01) when the PTX-NX
group was excluded; however, the CR to PTH was less in each of
the three NX groups than their respective dietary control with
normal renal function (P < 0.00 1). While phosphorus restriction
in the LPD-NX group maintained PTH levels in the normal range,
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Fig. 2. The calcemic response to an infusion of 0.11 p.g/100 g body wtlhr of
rat 1-34 PTH is shown as the delta calcium which is defined as the difference
between the post-PTH infusion and the basal serum calcium. The calcemic
response to PTH (delta calcium) is presented both in rats with normal
renal function (NRF groups) and rats with renal failure (NX groups). The
different maintenance diets are shown under each bar: HPD, high
phosphorus diet; MPD, moderate phosphorus diet; LPD, low phosphorus
diet. Parathyroidectomy (PTX) was performed in an additional NX group.
* P < 0.05 vs. NX groups; # P < 0.05 vs. NRF groups on similar main-
tenance diet.
PTH was still greater than in the LPD-NRF group which had the
lowest PTITI level of the three groups with normal renal function.
However, the PTH level in the LPD-NX group was similar to the
PTH level in the HPD-NRF group (49 3 vs. 48 4 pg/mI).
Nevertheless, despite similar serum PTH, phosphorus and calcit-
riol levels, the CR to PTH was less in the LPD-NX than the
HPD-NRF group (4.1 0.5 vs. 8.3 0.3 mg/dl, P < 0.001).
Finally, as shown in Figure 3, serum phosphorus decreased to a
similar level after the 48 hour infusion of PTH in all groups except
the PTX-NX group (P < 0.001).
As shown in Table 3, urinary calcium excretion on the mainte-
nance diets was not different in the three NRF and in the four NX
groups. During the PTH infusion, rats received a calcium free, low
phosphorus diet to minimize intestinal calcium and phosphorus
absorption. Among the three NRF and the four NX groups,
calcium excretion during the first and the second 24 hour periods,
and the total calcium excretion during the 48 hour PTH infusion
was similar in all groups except for the PTX-NX group in which
the calcium excretion during the first 24 hours was greater (P <
0.05). As serum calcium increased during the PTH infusion,
urinary calcium excretion was greater in the three NRF groups
during the second (24 to 48 hrs) than the first (0 to 24 hrs) 24-
hour collection period (P < 0.05). Similarly, urinary calcium
excretion was greater during the second 24 hours in the MPD-NX
and LPD-NX groups (P < 0.05). Urinary phosphorus excretion in
the maintenance diet groups reflected dietary phosphorus inges-
tion and was highest in the NRF and NX groups receiving a HPD
and lowest in the NRF and NX groups receiving a LPD (P <
0.005); phosphorus excretion was also low in the PTX-NX group.
No differences in the total urinary phosphorus excretion were
observed among the three NRF and the four NX groups during
the 48-hour PTH infusion.
To assess whether the high calcium diet given to the PTX-NX
group could have affected the CR to PTH, parathyroid intact
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Fig. 3. The serum phosphorus level before and after the 48-hour PTH
infusion is shown in rats with nonnal renalfunction (NRFgroups, A) and rats
with renal failure (NXgroups, B). Abbreviations are: HPD, high phospho-
rus diet; MPD, moderate phosphorus diet; LPD, low phosphorus diet;
PTX, parathyroidectomy; NS, differences not significant. Symbols are: (-R-)
MPD; (-4-) HPD; (..) LPD; (-/r -) PTX. * P < 0.05 vs. MPD-NX and
LPD-NX groups at 0 hours; # P < 0.05 vs. HPD-NX, MPD-NX, and
LPD-NX groups at 48 hours.
normal (HCaD-NRF) and azotemic (HCaD-NX) rats received
the same diet (Table 4). As designed, serum creatinine was
greater in the two nephrectomized groups. The CR to PTH in the
HCaD-NRF group was greater than in the HCaD-NX group, but
not different than in the PTX-NX group. Between the HCaD-
NRF and HCaD-NX groups, serum calcium and phosphorus were
similar, but serum PTH was greater and serum calcitriol was less
in the HCaD-NX group (P < 0.001).
An additional study was performed to determine whether the
effect of PTX on the CR to PTH was greater in rats with normal
renal function than azotemic rats. As compared with their respec-
tive control with the same renal function, PTX improved the CR
to PTH (P < 0.01; Fig. 4); moreover, the CR to PTH was greater
in the PTX-NRF group than the azotemic PTX group (PTX-NX;
P < 0.01). As presented in Table 5, serum creatinine was greater
in the nephrectomized groups, and serum calcium lower and
A NRF groups
9
7
NS
0 48
Time, hours
B NX groups
*
13
E ii
Cl)
0
0 48
Time, hours
NX PTX'NX
816
4
2
NRF FTX-NRF
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Table 3. Urinary data in normal and azotemic rats
Norma! renal function (NRF) Azotemic (NX)
HPD-NRF MPD-NRF LPD-NRF HPD-NX MPD-NX LPD-NX PTX-NX
Maintenance diet
Calcium mg124 hr 0.10 0.03 0.08 0.03 0.07 0.02 0.17 0.04 0.06 0.05 0.11 0.07 0.30 0.10
PTH infusion
Calcium 0—24 hr 0.11 0.02 0.07 0.01 0.07 0.02 0.14 0.02 0.10 0.04 0.10 0.02 0.25 O.O5a
mg/24 hr
Calcium 24—48 hr 0.17 O.03c 0.15 0.03° 0.18 0.05° 0.19 0.02 0.17 0.03° 0.18 0.03c 0.17 0.03
mg124 hr
Total calcium 0.28 0.05 0.23 0.05 0.25 0.16 0.34 0.02 0.27 0.07 0.28 0.05 0.42 0.06
mg148 hr
Maintenance diet
Phosphorus mg124 hr 51.7 9.0 15.8 2.3" 4.9 12ad 65.6 6.8 17.3 1.1" 73 5.8
PTH infusion
Phosphorus 0—24 hr 20.6 4.5 16.2 2.2 15.7 2.2 20.4 1.6 13.4 1.7 14.8 3.7 21.2 2.0
mg/24 hr
Phosphorus 24—48 hr 16.8 1.8 18.4 1.9 18.0 1.1 9.4 0.7° 14.5 2.3 12.1 2.4 11.9 1.8°
mg/24 hr
Total phosphorus 37.4 4.9 34.3 4.2 33.7 2.1 29.8 1.5 27.8 2.6 26.9 4.6 33.1 3.0
mg/48 hr
N 5 6 6 5 5 5 5
Data are mean SE. Abbreviations are: HPD, high phosphorus diet; MPD, moderate phosphorus diet; LPD, low phosphorus diet.
a P < 0.05 vs. MPD, same degree of renal functionbP < 0.05 vs. LPD, same degree of renal function
CP < 0.05 24—48 hr vs. 0—24 hrdP < 0.05 vs. HPD, same degree of renal function
Table 4. Biochemical data in rats fed a high calcium diet (HCaD)
HCaD-NRF HCaD-NX PTX-NX
Creatinine mg/dl 0.3 0.1 0.9 0.la 0.9 0.1'
Calcium mg/dl
Phosphorus mg/dl
10.0 0.2
8.2 0.4
10.0 0.2
7.7 0.3
7.8 0.4
12.1 07ab
PTH pg/mi 39 3 77 9 ND
Calcitriol pg/mi
Calcemic response to
153 12
8.5 0.5
98 12
3.5 0.5a
NM
7.7 0.6"
PTJT{ mg/dl
N 6 9 11
Data are mean SE. Abbreviations are: NRF, normal renal function;
NX, azotemic; PTX, parathyroidectomized; ND, non-detectable; NM, not
measured.
aP < 0.05 vs. HCaD-NRF group
b P < 0.05 vs. HCaD-NX group
serum phosphorus greater in the PTX groups than their respective
controls. During the 48-hour PTH infusion, while rats were
maintained on a calcium free, 0.16% phosphorus diet, urinary
calcium excretion was greater in the PTX-NX group as compared
to the PTX-NRF group (P < 0.01), but was not different between
the NRF and PTX-NRF groups. No differences in urinary phos-
phorus excretion were observed among the different groups.
Discussion
In the present study, PTX corrected the decreased CR to PTH
in azotemic rats to the range observed in normal rats; however,
the CR to PTH was not improved by a reduction of PTH levels
and not corrected by the maintenance of normal PTH levels. The
finding of a decreased CR to PTH in azotemic rats even when
normal PTH levels were maintained, together with the finding
that PTX corrected the CR to PTH in azotemic rats, suggest that
the restoration of the CR to PTH to normal by PTX is likely by a
mechanism different than down-regulation of bone receptors for
Fig. 4. The calcemic response to an infusion of 0.066 pgIlOO gbody wtlhr of
1-34 rat PTH is shown as the delta calcium which is defined as the difference
between the post-PTH infusion and the basal serum calcium. The calcemic
response to PTH (delta calcium) is presented in normal rats (NRF group),
PTX rats with normal renal function (PTX-NRF group), azotemic rats
(NX group) and PTX azotemic rats (PTX-NX group). * P < 0.05 vs.
corresponding NRF or PTX-NRF group; # P < 0.05 vs. same degree of
renal failure.
PTH. Finally, PTX resulted in a greater CR to PTH in rats with
normal renal function than azotemic rats.
Skeletal resistance to the calcemic action of PTH has been
reported to be an important factor in the development of 2° HPT
[1—3, 7—10]. Phosphorus retention [1, 11, 12], a calcitriol deficiency
[2, 13—15], and down-regulation of bone receptors for PTH [2, 16]
have all been reputed to contribute to the decreased CR to PTH
in uremia. While correction of phosphorus retention and the
calcitriol deficiency has been shown to impro'e the CR to PTH [1,
2, 11, 13, 22], normalization of the CR to PTH has only been
observed after the complete elimination of PTH by PTX [2, 16].
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Table 5. The effect of parathyroidectomy on the calcemic response to PTH
Normal rena! function Azotemic
NRF PTX-NRF NX PTX-NX
Serum data mg/dl
Creatinine 0.3 0.1 0.3 0.1 0.9 01gb 1.0 0.i'
Calcium 9.9 0.2 4.8 0.2a 10.0 02b 5.1
Phosphorus
Calcemic response to PTH
8.0 0.2
5.5 0.5
13.6 0.5°
8.5 0.8°
8.7 0•5b
1.8 0.7°"
13.4 0.5°°
5.2 0.2"°
Urinary data during PTH infusion
Calcium 0—24 hr 0.08 0.05 0.13 0.03 0.11 0.04 0.25 0.06°"
mg124 hr
Calcium 24—48 hr 0.05 0.01 0.10 0.02 0.18 0.06 0.33 0.09"
mg124 hr
Total calcium 0.13 0.06 0.22 0.01 0.30 0.10 0.59 0.09°"
mg/48 hr
Phosphorus 0—24 hr 15.6 2.3 18.1 2.3 13.4 2.6 15.7 1.2
mg124 hr
Phosphorus 24—48 hr 19.5 2.6 18.5 3.5 16.9 1.4 11.7 1.8
mg/24 hr
Total phosphorus 35.1 3.6 36.6 4.6 31.6 3.3 27.4 3.4
mg/48 hr
N 6 7 5 6
Data are mean SE. Abbreviations are: NRF, normal renal function; NX, azotemic; PTX, parathyroidectomized.
ap < 0.05 vs. NRF group
bp < 0.05 vs. PTX-NRF group
P < 0.05 vs. NX group
These results suggested that elevated PTH levels induced down-
regulation of bone receptors for PTH and PTX restored the
responsiveness of these receptors. As such, down-regulation of
PTH receptors has been considered to be an important factor in
the development of a decreased CR to PTH. However, the
relation between PTX and down-regulation of PTH receptors has
not been directly established and the possibility that PTX could
have restored the CR to PTH by a mechanism different than
down-regulation of PTH receptors has not been excluded.
Consequently, we reasoned that if high PTH levels induce
down-regulation of PTH receptors, a reduction of PTH levels may
improve the CR to PTH and prevention of elevated PTH levels
should normalize the CR to PTH. In the present study, the degree
of 2° HPT in renal failure was varied by controlling the phospho-
rus content of the diet. As has been shown previously, phosphorus
restriction reduced and phosphorus loading increased the magni-
tude of 2° HPT [4—6, 23]. The high phosphorus diet increased
PTH levels by approximately eightfold in azotemic rats (HPD-NX
group). The low phosphorus diet minimized the increase in PTH
and by selection, we were able to identify a subgroup of rats with
PTH levels in the normal range. However, our results indicate
that a reduction of PTH levels did not improve and the mainte-
nance of normal PTH levels did not correct the decreased CR to
PTH in azotemic rats. While the PTH levels in the LPD-NX group
were not as low as its dietary control group (LPD-NRF), the PTH
level in the LPD-NX group was similar to that of the HPD-NRF
group which had a normal CR to PTH. Thus, since serum
phosphorus and calcitriol levels were similar between the
LPD-NX and HPD-NRF groups, our results suggest that down-
regulation of bone receptors for PTH did not contribute to the
decreased CR to PTH in renal failure. These results are in
agreement with Kaplan et al, who reported a decreased CR to
PTH in azotemic dogs despite the presence of normal PTH levels
[17]. Furthermore, Massry et al have shown that infusing parathy-
roid extract to subtotally parathyroidectomized azotemic patients
with normal or minimal elevation of PTH did not improve the CR
to PTH [8].
Phosphorus retention has also been shown to be a factor in the
decreased CR to PTH observed in renal failure [1—3, 11, 22]. In
the present study, serum phosphorus levels were similar among
normal and azotemic groups except for the HPD-NX and
PTX-NX groups in which the phosphorus levels were greater.
Despite dietary phosphorus restriction, only a modest improve-
ment in the CR to PTH was observed in the LPD-NX group as
compared with the HPD-NX group. This result was similar to our
previous study in which phosphorus restriction induced only a
moderate improvement in the CR to PTH in azotemic rats [11.
Studies in patients with renal failure have also demonstrated
skeletal resistance to the calcemic action of PTH even when
serum phosphorus levels were low or normal [10, 24].
A deficiency of calcitriol has also been reported to contribute to
the decreased CR to PTH in renal failure [13, 14]; however, in
most studies calcitriol supplementation has only produced a
minimal improvement in the CR to PTH [2, 15, 17]. Thus, despite
normal calcitriol levels and phosphorus restriction, the CR to
PTH was significantly decreased in the LPD-NX group as com-
pared with normal rats. This result was similar to our previous
study in which a phosphorus restricted diet together with calcitriol
supplementation during the PTH infusion only moderately im-
proved the CR to PTH [2].
In the azotemic groups, serum calcitriol levels were higher in
the MPD-NX and LPD-NX groups than the HPD-NX group;
furthermore, the MPD-NX and LPD-NX groups had similar
calcitriol levels as their sham-operated controls (MPD-NRF and
LPD-NRF groups). This finding was likely due to a somewhat
restrictive calcium and phosphorus diet and a moderate increase
in PTH in the MPD-NX group together with relatively normal
tissue in the remnant kidney; in the LPD-NX group, dietary
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phosphorus restriction may have been an additional stimulus [25,
261. Moreover, our results of normal serum calcitriol levels in
azotemic rats are consistent with reports of other studies in which
azotemic rats were maintained on similar diets [3, 19, 20].
Since total urinary calcium excretion was similar in all groups,
this could not account for the differences in the CR to PTH. While
rats were ingesting negligible amounts of dietary calcium and
phosphorus during the 48-hour PTH infusion, calcium excretion
was similar in all groups except for the first 24 hours in the
PTX-NX group. As serum calcium increased during the second
24-hour period, calcium excretion was greater in the three NRF
and two of the NX groups. No differences in phosphorus excretion
were observed among the different groups during the 48-hour
PTH infusion and thus, could not be responsible for differences in
the CR to PTH.
The PTX-NX group was the only azotemic group with normal-
ization of the CR to PTH. In this group, the normalization of the
CR to PTH was observed despite the presence of increased serum
phosphorus levels and presumably low levels of serum calcitriol.
Although calcitriol levels were not measured in the PTX-NX
group, in previous studies calcitriol levels have been reported to
be low after a PTX [27—29]. Furthermore, in the present study
even normal serum calcitriol levels did not correct the CR to PTH
in other NX groups. Since only the PTX-NX group received a high
calcium diet in our initial studies, a high calcium diet was given to
both normal and azotemic rats to evaluate the effect of a high
calcium maintenance diet on the CR to PTH. Our results indicate
that the high calcium diet does not provide an explanation for the
normalization of the CR to PTH in the PTX-NX group.
Although the CR to PTH was similar in the PTX-NX group as
compared with the three groups with normal renal function, it was
possible that the CR to PTH could be even higher in PTX rats
with normal renal function. To determine whether such differ-
ences could be present, an additional study was performed. As
shown in Table 5, PTX in azotemic rats increased the CR to PTH
to the same range as normal rats (NRF group). However, PTX in
rats with normal renal function further increased the CR to PTH.
Thus, the CR to PTH was greater in the PTX-NRF group than
both the PTX-NX and NRF groups. While urinary calcium excretion
was similar between the NRF and the PTX-NRF groups and thus
could not account for the greater CR to PTFI in the PTX-NRF
group, urinary calcium excretion was greater in the PTX-NX than
the PTX-NRF group. According to our calculations, this difference
in urinary calcium excretion could account for approximately 50 to
60% of the difference in the CR to PTH. Finally, phosphorus
excretion was not different among the groups, and thus should not
have contributed to the difference in the CR to PTH.
Since serum PTH and calcitriol levels were normal and phos-
phorus retention unlikely on a phosphorus restricted diet [20], the
reason for the decreased CR to PTH in the LPD-NX group is
unclear. Thus, as we recently observed [3], it would appear that
factors inherent to uremia exclusive of changes in calcitriol and
phosphorus may inhibit the CR to PTH. Wills and Jenkins have
shown in an in vitro model that serum from uremic patients
inhibited PTH-induced bone resorption and this inhibitory effect
was not present in serum obtained after dialysis [30]. In the same
study, specific uremic metabolites were shown to inhibit the effect
of PTH-induced bone resorption. Moreover, on the clinical level,
it has been shown that higher PTH levels are needed to maintain
normal histological parameters in dialysis patients [31, 32] and
furthermore, even higher PTH levels are required in predialysis than
in dialysis patients to achieve the same degree of bone remodeling
[331. Thus, it is possible that factors inherent to uremia may
contribute to the decreased CR to PTH in renal failure.
The mechanism by which the elimination of high circulating
PTH levels by PTX in azotemic rats normalizes the CR to PTH is
not known. While down-regulation of PTH receptors is an
attractive hypothesis, the failure of normal PTH levels to correct
the CR to PTH in azotemic rats suggests that other possibilities
should be considered. Supporting this conclusion are the prelim-
inary results by Berdud et al [341; in this study the CR to PTH was
decreased in azotemic PTX rats in which normal PTH levels were
maintained by using a subcutaneously implanted miniosmotic
pump to infuse 1-34 rat PTH. Finally, the mechanism by which the
decreased CR to PTH in azotemic rats is corrected by PTX is of
considerable interest because this normalization even surmounts
known inhibitory factors such as hyperphosphatemia, a calcitriol
deficiency and renal failure.
While no facile explanation is available to explain how PTX
improves the CR to PTH, parathyroidectomy has been shown to
have several effects on the calcium exchange between the extra-
cellular fluid and bone. Several authors have documented that
PTX decreases the exchangeable calcium bone pool [35, 36] and
thus, a calcium infusion increases serum calcium more rapidly in
parathyroidectomized than normal rats [371. Nevertheless, this
still does not explain how PTX corrects the CR to PTH in uremia.
However, a review of the studies in which Copp was led to believe
in the early 1960's that the parathyroid glands were the source of
calcitonin provide data which suggest that PTX may directly
enhance the CR to PTH [37]. First, it was shown that the CR to
parathyroid extract was greater in PTX than normal rats [38].
Second, after a nine hour infusion of parathyroid extract induced
moderate hypercalcemia in rats, a PTX performed at the end of
the infusion resulted in a marked increase in serum calcium [39].
Finally, Copp also showed that a PTX performed immediately
after the induction of hypocalcemia resulted in an overcompen-
sation in serum calcium during the recovery from hypocalcemia
[37]. Thus, as a result of these studies, Copp mistakenly localized
calcitonin to the parathyroid gland. However, since we now know
that calcitonin was not responsible for the observed results, a
reasonable interpretation of these studies would be that PTX
enhanced the CR to PTI-{ and this enhancement was not due to
down-regulation of bone receptors for PTH.
In summary, we have shown that while PTX improved the CR
to PTH to the normal range in renal failure, a significant
reduction of PTH levels by dietary manipulation did not improve
the CR to PTH, and maintenance of normal PTH levels did not
correct the CR to PTH. A decreased CR to PTH was observed in
azotemic rats on a low phosphorus diet despite the absence of
phosphorus retention, a calcitriol deficiency and an elevation in
PTH. Furthermore, the CR to PTH was greater in non-azotemic
PTX rats than both azotemic PTX and normal rats. Thus, in
conclusion, our results suggest that the mechanism by which PTX
restores the CR in uremia may include factors other than down-
regulation of PTH receptors, and uremia may be an independent
factor contributing to the decreased CR to PTH.
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